3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
4
Gastrointestinal Stromal Tumors
4
Philadelphia Chromosome
1
Myeloproliferative Disorders
1
Melanoma
1
Digestive System Neoplasms
1
Congenital Bone Marrow Failure Syndromes
1
Burkitt Lymphoma
1
Blast Crisis
1
Interventions
peginterferon alfa-2b
1
fludarabine phosphate
1
Whole-Body Irradiation
1
Tacrolimus
1
Specimen Handling
1
Sirolimus
1
Peripheral Blood Stem Cell Transplantation
1
Mycophenolic Acid
1
Methotrexate
1
Melphalan
1
Hyperbaric Oxygenation
1
Etoposide
1
Cyclosporine
1
Cyclophosphamide
1
Busulfan
1
Biopsy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative
×
Imatinib Mesylate
×
30 days
×
Clear all
No trials found.